These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 33990626)

  • 41. Generation of a pluripotent stem cell line (UMGi270-A) and a corresponding CRISPR/Cas9 modified isogenic control (UMGi270-A-1) from a patient with sudden onset dilated cardiomyopathy harboring a FLNC p.R2187P mutation.
    Maurer W; Rebs S; Köhne S; Eberl H; Wollnik B; Zibat A; Streckfuss-Bömeke K
    Stem Cell Res; 2024 Jun; 77():103409. PubMed ID: 38583294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model.
    Wang Z; Wang L; Liu W; Hu D; Gao Y; Ge Q; Liu X; Li L; Wang Y; Wang S; Li C
    Stem Cell Res; 2019 Jul; 38():101483. PubMed ID: 31226583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeted addition of mini-dystrophin into rDNA locus of Duchenne muscular dystrophy patient-derived iPSCs.
    Zeng B; Zhou M; Liu B; Shen F; Xiao R; Su J; Hu Z; Zhang Y; Gu A; Wu L; Liu X; Liang D
    Biochem Biophys Res Commun; 2021 Mar; 545():40-45. PubMed ID: 33540285
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Creation of a Novel Humanized Dystrophic Mouse Model of Duchenne Muscular Dystrophy and Application of a CRISPR/Cas9 Gene Editing Therapy.
    Young CS; Mokhonova E; Quinonez M; Pyle AD; Spencer MJ
    J Neuromuscul Dis; 2017; 4(2):139-145. PubMed ID: 28505980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Derivation of the Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line lacking DMD exons 49 and 50 (CCMi001DMD-A-3, ∆49, ∆50).
    Spaltro G; Vigorelli V; Casalnuovo F; Spinelli P; Castiglioni E; Rovina D; Paganini S; Di Segni M; Nigro P; Gervasini C; Pompilio G; Gowran A
    Stem Cell Res; 2017 Dec; 25():128-131. PubMed ID: 29127875
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytes.
    Shiba M; Higo S; Kondo T; Li J; Liu L; Ikeda Y; Kohama Y; Kameda S; Tabata T; Inoue H; Nakamura S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
    Hum Mol Genet; 2021 Jul; 30(15):1384-1397. PubMed ID: 33949662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dystrophin Deficiency Causes Progressive Depletion of Cardiovascular Progenitor Cells in the Heart.
    Jelinkova S; Sleiman Y; Fojtík P; Aimond F; Finan A; Hugon G; Scheuermann V; Beckerová D; Cazorla O; Vincenti M; Amedro P; Richard S; Jaros J; Dvorak P; Lacampagne A; Carnac G; Rotrekl V; Meli AC
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery.
    Guan X; Mack DL; Moreno CM; Strande JL; Mathieu J; Shi Y; Markert CD; Wang Z; Liu G; Lawlor MW; Moorefield EC; Jones TN; Fugate JA; Furth ME; Murry CE; Ruohola-Baker H; Zhang Y; Santana LF; Childers MK
    Stem Cell Res; 2014 Mar; 12(2):467-80. PubMed ID: 24434629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutations in DNAJC19 cause altered mitochondrial structure and increased mitochondrial respiration in human iPSC-derived cardiomyocytes.
    Janz A; Walz K; Cirnu A; Surjanto J; Urlaub D; Leskien M; Kohlhaas M; Nickel A; Brand T; Nose N; Wörsdörfer P; Wagner N; Higuchi T; Maack C; Dudek J; Lorenz K; Klopocki E; Ergün S; Duff HJ; Gerull B
    Mol Metab; 2024 Jan; 79():101859. PubMed ID: 38142971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A muscle fatigue-like contractile decline was recapitulated using skeletal myotubes from Duchenne muscular dystrophy patient-derived iPSCs.
    Uchimura T; Asano T; Nakata T; Hotta A; Sakurai H
    Cell Rep Med; 2021 Jun; 2(6):100298. PubMed ID: 34195678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9.
    Sui T; Lau YS; Liu D; Liu T; Xu L; Gao Y; Lai L; Li Z; Han R
    Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29871865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation of human induced pluripotent stem cell lines with HMOX1 promoter polymorphism and CRISPR/Cas9-mediated deletion of exon 50 of DMD gene.
    Polak K; Stępniewski J; Ścieżyńska A; Podgórska A; Dulak J; Florczyk-Soluch U
    Stem Cell Res; 2023 Feb; 66():103004. PubMed ID: 36565681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrated Ca
    Malkovskiy AV; Ignatyeva N; Dai Y; Hasenfuss G; Rajadas J; Ebert A
    Biol Chem; 2020 Nov; 402(1):113-121. PubMed ID: 33544492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel mouse model of Duchenne muscular dystrophy carrying a multi-exonic
    Wong TWY; Ahmed A; Yang G; Maino E; Steiman S; Hyatt E; Chan P; Lindsay K; Wong N; Golebiowski D; Schneider J; Delgado-Olguín P; Ivakine EA; Cohn RD
    Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32988972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes.
    Ceholski DK; Turnbull IC; Kong CW; Koplev S; Mayourian J; Gorski PA; Stillitano F; Skodras AA; Nonnenmacher M; Cohen N; Björkegren JLM; Stroik DR; Cornea RL; Thomas DD; Li RA; Costa KD; Hajjar RJ
    J Mol Cell Cardiol; 2018 Jun; 119():147-154. PubMed ID: 29752948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of three Duchenne Muscular Dystrophy patient-specific induced pluripotent stem cell lines DMD_YoTaz_PhyMedEXp, DMD_RaPer_PhyMedEXp, DMD_OuMen_PhyMedEXp (INSRMi008-A, INSRMi009-A and INSRMi010-A).
    Souidi M; Amédro P; Meyer P; Desprat R; Lemaître JM; Rivier F; Lacampagne A; Meli AC
    Stem Cell Res; 2020 Dec; 49():102094. PubMed ID: 33246213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy.
    Perea-Gil I; Seeger T; Bruyneel AAN; Termglinchan V; Monte E; Lim EW; Vadgama N; Furihata T; Gavidia AA; Arthur Ataam J; Bharucha N; Martinez-Amador N; Ameen M; Nair P; Serrano R; Kaur B; Feyen DAM; Diecke S; Snyder MP; Metallo CM; Mercola M; Karakikes I
    Eur Heart J; 2022 Sep; 43(36):3477-3489. PubMed ID: 35728000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiomyocyte-produced miR-339-5p mediates pathology in Duchenne muscular dystrophy cardiomyopathy.
    Gartz M; Beatka M; Prom MJ; Strande JL; Lawlor MW
    Hum Mol Genet; 2021 Nov; 30(23):2347-2361. PubMed ID: 34270708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic and Pharmacological YAP Activation Induces Proliferation and Improves Survival in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Bui TA; Stafford N; Oceandy D
    Cells; 2023 Aug; 12(17):. PubMed ID: 37681853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tamoxifen treatment ameliorates contractile dysfunction of Duchenne muscular dystrophy stem cell-derived cardiomyocytes on bioengineered substrates.
    Birnbaum F; Eguchi A; Pardon G; Chang ACY; Blau HM
    NPJ Regen Med; 2022 Mar; 7(1):19. PubMed ID: 35304486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.